Healthcare
Unbalanced Care
Nurse Migration in the Philippines
In many developing countries, notably the Philippines and several African nations, native-born nurses and health professionals have economic incentives to emigrate to industrialized countries. The rate of this emigration has increased in recent years. Many have expressed concerns about the long-term damage emigration imposes on the health-care systems of the health professionals’ home nations, as well as the risks it poses to those in the home country that are in need of treatment.
This paper focuses on the migration of nurses. It analyzes the issue in the context of globalization and describes the economic effects on the nurses’ home countries and the countries in which they later settle and work. This paper discusses some of the major policy issues associated with nurse migration and suggests how stakeholder organizations and institutions might play a role in crafting a policy that attempts to serve the interests of these nurses and of the health-care systems of both the home and destination countries. Although it does not offer a solution, this paper aims to provide a foundation for those interested in working towards a solution.
Published In: Volume 4, Issue 4: — December 4, 2007
Emergency Contraception
Getting Medicine's Best Kept Secret into the Hands of American Women
Emergency Contraception is safe, effective, and available over the counter – yet many are unaware of its existence. This article discusses barriers to the widespread adoption of emergency contraception, ways to overcome them, and alternative methods to reduce unintended pregnancies and abortions in the United States.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — November 29, 2006
Marla Bertagnolli
Associate Director, CIVIC
Published In: Volume 3, Issue 2: Modern Healthcare Policy — November 16, 2006
Health Care Costs: Do We Need a Cure?
Published In: Volume 3, Issue 2: Modern Healthcare Policy — November 5, 2006
Comprehensive Care for HIV/AIDS
The challenge goes beyond antiretroviral accessibility
The price of anti-retroviral treatment is prohibitive for most patients in developing countries, but a new integrated approach may succeed at reversing the pandemic by addressing more than just access to medication.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Redesigning the US' Healthcare Model
We must take steps towards solving the nation’s health care crisis, without employing elements of failed private managed care.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
The Medicare Prescription Drug Benefit
Serious flaws; should be amended, not repealed.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
The MMA should be repealed and replaced
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Healthcare Delivery Systems in Rural India
Meeting the changing needs of rural populations
How will India’s delivery of healthcare impact its future success as a global competitor? The author assesses the ways in which India’s current healthcare system both fails and succeeds in serving India’s rural population and looks at the impact this may have on the country’s future.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Outsourcing Care
Replacing Medicaid with Cross-Border Care in Texas
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Mental Health Parity
Legislation and Implications for Insurers and Providers
Ten years after the Mental Health Parity Act passed, which mandated equitable insurance coverage for mental health problems, insurers and providers still debate the issue.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Dr. Karen Feinstein
President and CEO, The Jewish Healthcare Foundation
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Dr. Jonathan Gruber
Professor of Economics, MIT
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Powerful Medicines: The benefits, risks, and costs of prescription drugs; by Jerry Avorn
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
Price Controls on U.S. Pharmaceuticals
Is this Good Public Policy?
The structure of the US pharmeceutical industry has given drug manufactures a large degree of control on the price of new medications. This article explores the implications of price controls on the pharmaceutical industry, weighs the benefits and costs of regulation, and compares the United States with international examples of price controls.
Published In: Volume 3, Issue 2: Modern Healthcare Policy — October 13, 2006
A Conversation with Leo W. Gerard
Published In: Volume 3, Issue 1: Globalization and its Implications — March 24, 2006